tradingkey.logo

Bionano Genomics Inc

BNGO

1.790USD

0.000
終値 09/19, 16:00ET15分遅れの株価
7.00M時価総額
損失額直近12ヶ月PER

Bionano Genomics Inc

1.790

0.000
詳細情報 Bionano Genomics Inc 企業名
Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
企業情報
企業コードBNGO
会社名Bionano Genomics Inc
上場日Aug 01, 2018
最高経営責任者「CEO」Dr. R. Erik Holmlin, Ph.D.
従業員数98
証券種類Ordinary Share
決算期末Aug 01
本社所在地9540 Towne Centre Drive
都市SAN DIEGO
証券取引所NASDAQ Capital Market Consolidated
United States of America
郵便番号92121
電話番号18588887600
ウェブサイトhttps://bionano.com/
企業コードBNGO
上場日Aug 01, 2018
最高経営責任者「CEO」Dr. R. Erik Holmlin, Ph.D.
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-13.38%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-2.58%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.91%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-84.26%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Mr. David Holmes
Mr. David Holmes
Investor Relations Officer
Investor Relations Officer
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-13.38%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-2.58%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.91%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-84.26%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
事業別USD
会社名
収益
比率
Consumables
3.25M
50.29%
Software
2.07M
32.03%
Instruments
689.00K
10.67%
Services and other
453.00K
7.02%
地域別USD
会社名
収益
比率
EMEIA
3.07M
47.48%
Americas
3.06M
47.36%
Asia Pacific
333.00K
5.16%
事業別
地域別
事業別USD
会社名
収益
比率
Consumables
3.25M
50.29%
Software
2.07M
32.03%
Instruments
689.00K
10.67%
Services and other
453.00K
7.02%
株主
更新時刻: Fri, Sep 19
更新時刻: Fri, Sep 19
株主統計
種類
株主統計
株主統計
比率
Lincoln Alternative Strategies LLC
5.42%
GSA Capital Partners LLP
0.41%
Geode Capital Management, L.L.C.
0.19%
Parametric Portfolio Associates LLC
0.11%
BlackRock Institutional Trust Company, N.A.
0.10%
他の
93.75%
株主統計
株主統計
比率
Lincoln Alternative Strategies LLC
5.42%
GSA Capital Partners LLP
0.41%
Geode Capital Management, L.L.C.
0.19%
Parametric Portfolio Associates LLC
0.11%
BlackRock Institutional Trust Company, N.A.
0.10%
他の
93.75%
種類
株主統計
比率
Corporation
5.42%
Hedge Fund
0.44%
Investment Advisor
0.28%
Investment Advisor/Hedge Fund
0.19%
Research Firm
0.12%
Individual Investor
0.02%
他の
93.52%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
193
352.54K
10.48%
-62.70K
2025Q1
262
309.73K
9.24%
-123.47K
2024Q4
284
105.26K
3.91%
-124.97K
2024Q3
298
94.17K
6.55%
-135.04K
2024Q2
310
116.15K
9.81%
-164.95K
2024Q1
318
86.19K
9.42%
-64.99K
2023Q4
324
107.44K
14.24%
-23.70K
2023Q3
345
94.81K
16.11%
-27.58K
2023Q2
356
93.86K
18.29%
-63.50K
2023Q1
366
141.65K
27.72%
-15.82K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Geode Capital Management, L.L.C.
15.51K
0.46%
-1.12K
-6.75%
Mar 31, 2025
Parametric Portfolio Associates LLC
11.49K
0.34%
+11.49K
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
10.10K
0.3%
-4.00
-0.04%
Mar 31, 2025
BofA Global Research (US)
8.39K
0.25%
+8.37K
+41865.00%
Mar 31, 2025
Osaic Holdings, Inc.
3.21K
0.1%
+3.03K
+1722.73%
Mar 31, 2025
UBS Financial Services, Inc.
1.91K
0.06%
-22.00
-1.14%
Mar 31, 2025
Group One Trading, L.P.
1.79K
0.05%
-2.63K
-59.47%
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
日付
種類
比率
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
KeyAI